RA
REGN icon

Rational Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Rational Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,060
Closed -$1.69M – 295
2023
Q1 		$1.69M Buy
+2,060
New +$1.55M 0.14% 66
2021
Q1 		– Sell
-1,800
Closed -$870K – 222
2020
Q4 		$870K Buy
1,800
+1,778
+8,082% +$960K 0.23% 107
2020
Q3 		$12K Sell
22
-6
-21% -$3.64K 0.01% 268
2020
Q2 		$17K Buy
+28
New +$15.9K 0.01% 301
2020
Q1 		– Sell
-24
Closed -$9K – 443
2019
Q4 		$9K Sell
24
-236
-91% -$79.4K ﹤0.01% 457
2019
Q3 		$72K Buy
260
+180
+225% +$53.3K 0.03% 322
2019
Q2 		$25K Sell
80
-5,017
-98% -$1.67M 0.01% 418
2019
Q1 		$2.09M Buy
5,097
+5,073
+21,138% +$2.09M 0.57% 65
2018
Q4 		$9K Buy
24
+22
+1,100% +$8.05K ﹤0.01% 395
2018
Q3 		$1K Sell
2
-1
-33% -$381 ﹤0.01% 507
2018
Q2 		$1K Buy
+3
New +$938 ﹤0.01% 488
2015
Q3 		$12K Hold
25
– – ﹤0.01% 314
2015
Q2 		$13K Hold
25
– – ﹤0.01% 317
2015
Q1 		$11K Sell
25
-16
-39% -$6.78K ﹤0.01% 340
2014
Q4 		$17K Buy
+41
New +$16.1K ﹤0.01% 369
2013
Q4 		$667K Buy
2,423
+646
+36% +$186K 0.06% 319
2013
Q3 		$556K Sell
1,777
-73
-4% -$19.2K 0.04% 376
2013
Q2 		$416K Buy
+1,850
New +$431K 0.03% 404

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rational Advisors's REGN Position: Q2 2023 in Review

Rational Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2023, closing a stake of 2,060 shares — an estimated $1.69M sold.

Rational Advisors first reported a position in REGN in Q2 2013 and held it in 18 quarters. The position peaked at $2.09M in Q1 2019. 1,164 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

  • Rational Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Rational Advisors sold 2,060 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $1.69M.
  • Rational Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Rational Advisors's Regeneron Pharmaceuticals position peaked at $2.09M in Q1 2019.
  • 1,164 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Rational Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.